PuSH - Publikationsserver des Helmholtz Zentrums München

Export: TXT Text RIS Endnote (RIS) BIB BibTeX
Belavgeni, A.* ; Maremonti, F.* ; Tonnus, W.* ; Stadtmüller, M.* ; Gavali, S.* ; Mallais, M.* ; Flade, K.* ; Brucker, A.J.* ; Becker, J.N.* ; Beer, K.* ; Tmava, M.* ; Stumpf, J.* ; Gembardt, F.* ; Hugo, C.* ; Giacca, M.* ; Hale, B.G.* ; Perakakis, N.* ; Sha, W.* ; Pratt, D.A.* ; Schally, A.V.* ; Bornstein, S.R. ; Linkermann, A.*

vPIF-1 is an insulin-like antiferroptotic viral peptide.

Proc. Natl. Acad. Sci. U.S.A. 120:e2300320120 (2023)
Verlagsversion DOI PMC
Open Access Hybrid
Creative Commons Lizenzvertrag
Iridoviridae, such as the lymphocystis disease virus-1 (LCDV-1) and other viruses, encode viral insulin–like peptides (VILPs) which are capable of triggering insulin receptors (IRs) and insulin-like growth factor receptors. The homology of VILPs includes highly conserved disulfide bridges. However, the binding affinities to IRs were reported to be 200- to 500-fold less effective compared to the endogenous ligands. We therefore speculated that these peptides also have noninsulin functions. Here, we report that the LCDV-1 VILP can function as a potent and highly specific inhibitor of ferroptosis. Induction of cell death by the ferroptosis inducers erastin, RSL3, FIN56, and FINO2 and nonferroptotic necrosis produced by the thioredoxin-reductase inhibitor ferroptocide were potently prevented by LCDV-1, while human insulin had no effect. Fas-induced apoptosis, necroptosis, mitotane-induced cell death and growth hormone–releasing hormone antagonist–induced necrosis were unaffected, suggesting the specificity to ferroptosis inhibition by the LCDV-1 VILP. Mechanistically, we identified the viral C-peptide to be required for inhibition of lipid peroxidation and ferroptosis inhibition, while the human C-peptide exhibited no antiferroptotic properties. In addition, the deletion of the viral C-peptide abolishes radical trapping activity in cell-free systems. We conclude that iridoviridae, through the expression of insulin-like viral peptides, are capable of preventing ferroptosis. In analogy to the viral mitochondrial inhibitor of apoptosis and the viral inhibitor of RIP activation (vIRA) that prevents necroptosis, we rename the LCDV-1 VILP a viral peptide inhibitor of ferroptosis-1. Finally, our findings indicate that ferroptosis may function as a viral defense mechanism in lower organisms.
Impact Factor
Scopus SNIP
Web of Science
Times Cited
Scopus
Cited By
Altmetric
11.100
2.765
3
2
Tags
Anmerkungen
Besondere Publikation
Auf Hompepage verbergern

Zusatzinfos bearbeiten
Eigene Tags bearbeiten
Privat
Eigene Anmerkung bearbeiten
Privat
Auf Publikationslisten für
Homepage nicht anzeigen
Als besondere Publikation
markieren
Publikationstyp Artikel: Journalartikel
Dokumenttyp Wissenschaftlicher Artikel
Schlagwörter regulated necrosis; ferroptosis; viral defense; necroptosis; apoptosis; Cell-death; Ferroptosis; Metabolism; Mechanism; Apoptosis; Kinase
Sprache englisch
Veröffentlichungsjahr 2023
HGF-Berichtsjahr 2023
ISSN (print) / ISBN 0027-8424
e-ISSN 1091-6490
Zeitschrift Proceedings of the National Academy of Sciences of the United States of America
Quellenangaben Band: 120, Heft: 21, Seiten: , Artikelnummer: e2300320120 Supplement: ,
Verlag National Academy of Sciences
Verlagsort 2101 Constitution Ave Nw, Washington, Dc 20418 Usa
Begutachtungsstatus Peer reviewed
Institut(e) Institute of Pancreatic Islet Research (IPI)
POF Topic(s) 90000 - German Center for Diabetes Research
Forschungsfeld(er) Helmholtz Diabetes Center
PSP-Element(e) G-502600-007
Förderungen transCampus initiative
Natural Sciences and Engineering Research Council of Canada
German Research Foundation (Deutsche Forschungsgemeinschaft, DFG)
international research training group
BMBF (Bundesministerium fuer Bildung und Forschung, FERROPath consortium)
Medical Clinic 3, University Hospital Carl Gustav Carus Dresden, Germany
DOI 10.1073/pnas.2300320120
WOS ID 001039496800001
Scopus ID 85159407818
PubMed ID 37186845
Erfassungsdatum 2023-12-11
[➜Korrektur melden]